Symbol
CADL on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%

Northpond Ventures, LP ownership in Candel Therapeutics, Inc. Common Stock (CADL)

14 Feb 2025 - Northpond Ventures, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Candel Therapeutics, Inc. Common Stock (CADL). This represents 0% ownership of the company. This is the first filing by Northpond Ventures, LP disclosing ownership of Candel Therapeutics, Inc. Common Stock (CADL).